Full List of Charles Raison's Publications

  1. Raison, C.L., Guze, B.H., Kissell, R.L. Successful treatment of clozapine-induced agranulocytosis with granulocyte colony-stimulating factor (letter). Journal of Clinical Psychopharmacology 1994; 14:285-86.
  2. Raison, C.L., Klein, H.M. Psychotic mania associated with fenfluramine and phentermine use (letter). American Journal of Psychiatry 1997; 154: 711.3.
  3. Raison C.L., Klein H.M., Steckler M. The Moon and Madness reconsidered. 1998. Journal of Affective Disorders 53; 1: 99-106.
  4. Raison, C.L., Miller, A.H. The Neuroimmunology of Stress and Depression. Seminars in Clinical Neuropsychiatry. 2001. 6; 4: 277-294.
  5. Raison, C.L., Marcin, M., Miller, A.H. Antidepressant treatment of cytokine-induced depression. Acta Neuropsychiatrica. 2002: 4.
  6. Capuron, L., Raison, C.L., Lawson, D.H., Musselman, D.L., Su, C., Nemeroff, C.B., Miller, A.H. An exaggerated HPA axis response to initial injection of interferon-alpha is associated with depression during interferon-alpha therapy. American Journal of Psychiatry 2003; 160(7): 1342-1345.
  7. Raison, C.L. & Miller, A.H. When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related Disorders. American Journal of Psychiatry. 2003; 160: 1554-1565.
  8. Raison, C.L. & Miller, A.H. Depression in Cancer: New Developments Regarding Diagnosis and Treatment. Biological Psychiatry, 2003; 54: 283-294.
  9. Asnis, G.M., De La Garza II, R, Miller, A.H., Raison, C.L., Ribavirin May Be an Important Factor in IFN-Induced Neuropsychiatric Effects. Journal of Clinical Psychiatry 2004; 65(4): 581.
  10. Raison, C.L., Broadwell, S.D., Borisov, A.S., Manatunga, A.K., Woolwine,B.J., Jacobson, I.M., Nemeroff, C.B., Miller, A.H. Depressive symptoms and viral clearance in patients receiving IFN-alpha and Ribavirin for Hepatitis C. Brain, Behavior and Immunity 2005; 19: 23-27.
  11. Raison, C.L., Borisov, Broadwell, S.D., A.S., Manatunga, A.K., Woolwine, B.J., Jacobson, I.M., Nemeroff, C.B., Miller, A.H. Depression during pegylated IFN-alpha plus ribavirin therapy: prevalence and prediction. Journal of Clinical Psychiatry 2005; 66;1:41-48.
  12. Raison, C.L., Demetrashvili, M., Capuron, L., Miller, A.H. Neuropsychiatric Side Effects of Interferon-alpha: Recognition and Management. CNS Drugs, 2005; 19(2): 1-19.
  13. Raison,C.L., Demetrashvili, M., Capuron L., Miller A.H. The authors' reply. CNS Drugs 2005. 19(8):721-2.
  14. Miller, A.H., Capuron, L., Raison, C.L. Immunologic influences on emotion regulation. Clinical Neuroscience Research 2005; 4(5-6): 235-333.
  15. Yoshida, K., Alagbe, O., Wan, X., Woolwine, B., Thornbury, M., Raison, C.L., Miller, A.H. Promotor polymorphisms of the interferon-alpha receptor gene and development of interferon-induced depressive symptoms in patients with chronic hepatitis C. Neuropsychobiology 2005; 52(2):55-61.
  16. Raison,C,L., Capuron L., Miller A.H. Depressive symptoms and viral clearance: In response. Brain, Behavior, and Immunity 2005; 19(4):273-4.
  17. Raison, C.L., Capuron, L., Miller, A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 2006. 27(1): 24-31.
  18. Silverman, M.N., Macdougall, M.G., Raison, C.L., Miller, A.H. Endogenous glucocorticoids protect against TNF-alpha-induced increases in anxiety-like behavior in virally-infected mice. Molecular Psychiatry 2007; 12(4): 408-17.
  19. Raison, C.L., Woolwine, B.J., Binongo, J., Demitrashvili, M.F., Borisov, A.F., Weinreib, R., Staab, J.P., Zajecka, J.M., Bruno, C.J., Henderson, M.A., Reinus, J.F., Evans, D.L., Asnis, G.M., Miller, A.H. Paroxetine for Prevention of Depressive Symptoms Induced by Interferon-alpha plus Ribavirin for Hepatitis C. Alimentary Pharmacology & Therapeutics 2007; 25(10): 1163-74.
  20. Majer, M., Welberg, L.A., Capuron, L., Pagnoni, G., Raison, C.L., Miller, A.H. IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain, Behavior, and Immunity 2008; 22(6): 870-80.
  21. Evans, D., Buxton, D.C., Borisov, A.S., Manatunga, A.K., Ngodup, D., Raison, C.L. (corresponding author). Shattered Shangri-la: differences in depressive and anxiety symptoms in students born in Tibet compared to Tibetan students born in exile. Social Psychiatry and Psychiatric Epidemiology 2008; 43(6): 429-36.
  22. Raison, C.L., Woolwine, B.J., Borisov, A.S., Cowles, Alagbe, O., M.,Vogt, G., Miller, A.H. Effects of Interferon-alpha on diurnal hypothalamic-pituitary-adrenal axis activity and behavior in patients with hepatitis C. Molecular Psychiatry 2010; 15: 535–547.
    27
  23. Raison, C.L., Borisov, A.S., Woolwine, B.J., Vogt, G.J., Massung, B. Miller, A.H. Activation of CNS inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biological Psychiatry 2009; 65(4):296-303.
  24. Pace, T.W.W., Negi, L.T., Adame, D, Cole, S.P., Sivilli, T.S., Brown, T., Issa, M., Raison, C.L. Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology 2009; 34(1):87-98.
  25. Raison, C.L. Lin, J.S., Reeves, W.C. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain, Behavior and Immunity 2009; 23(3):327-37.
  26. Nater, U.M., Lin, J.M., Maloney, E.H., Jones, J.F., Tian, H., Boneva, R.S., Raison, C.L., Reeves, W.C. Psychiatric Comorbidityin Persons with Chronic Fatigue Syndrome Identified from the Georgia Population.Psychosomatic Medicine 2009, Epub.
  27. Miller, A.H., Maletic, V., Raison, C.L. Inflammation and its discontents:the role of cytokines in the pathophysiology of major depression. Biological Psychiatry 2009; 65(9):732-41.
  28. Maletic, V. & Raison, C.L. At the Crossroads of Mind and Body: Focus on the Neurobiology of Depression, Fibromyalgia and Neuropathic Pain. Frontiers in Bioscience 2009. 14: 5291-5338.
  29. Pace, T.W.W., Negi, L.T., Sivilli, T.S., Issa, M.J., Cole, S.P., Adame, D.D., Raison, C.L. Innate Immune, Neuroendocrine and Behavioral Responses to Psychosocial Stress do not predict Subsequent Compassion Meditation Practice Time. Psychoneuroendocrinology 2010; 35: 310-15.
  30. Raison, C.L., Dantzer, R. Kelley, K.W., Lawson, M.A., Woolwine, B.J., Vogt, G., Spivey, J.R., Saito, K., Miller, A.H. CSF Concentrations of Brain Tryptophan and Kynurenines during Immune Stimulation with IFN-alpha: Relationship to CNS Immune Responses and Depression. Molecular Psychiatry 2010;15: 393-403.
  31. Johnson, T.V., Abbasi, A., Ehrlich, S.S., Kleris, S.S., Chirumamilla, S.L., Schoenberg, E.D., Owen-Smith, A., Raison, C.L., Master, V.A/ (2010) Major depression drives severity of American Urological Association Symptom Score. Urology 2010. 76(6):1317-1320.
  32. .Nater, U.M., Lin, J.M., Maloney, E.H., Jones, J.F., Tian, H., Boneva, R.S., Raison, C.L., Reeves, W.C. Criteria for chronic fatigue syndrome and co-morbid psychiatric conditions—Response to Kindlon. Psychosomatic Medicine 2009. 71(5):557-65.
  33. Johnson, T.V.,Abbasi, A., Ehrlich, S.S., Kleris, S.S., Chirumamilla, S.L., Schoenberg, E.D., Owen-Smith, A., Raison, C.L., Master, V.A. Nocturia associated with depressive symptoms. Urology 2011. 77(1):183-6.
  34. Raison, C.L., Rye, D.B., Woolwine, B.J., Vogt, G., Bautista, B.M., Spivey, J., Miller, A.H. Chronic Interferon-Alpha Administration Disrupts Sleep Continuity and Depth in Patients with Hepatitis C: Association with Fatigue, Motor Slowing and Increased Evening Cortisol. Biological Psychiatry 2010;68(10): 942-9.
  35. Johnson, T.V., Abbasi, A., Ehrlich, S.S., Kleris, R.S., Chirumamilla, S.L., Schoenberg, E.D., Owen-Smith, A., Raison, C.L., Master, V.A. Major depression drives severity of American urological association symptom index. Urology 2010;76(6): 1317-20.
  36. Raison, C.L., Lowry, C.A., Rook, G.A.W. Inflammation, Sanitation and Consternation: Loss of Contact with Co-Evolved, Tolerogenic Micro-Organisms and the Pathophysiology and Treatment of Major Depression, Archives of General Psychiatry 2010 67(12):1211-24.
  37. Rook, G.A.W., Lowry, C.A., Raison, C.L. Lymphocytes in Neuroprotection, Cognition and Emotion: is Intolerance Really the Answer? Brain, Behavior and Immunity 2011; 25(4): 591-601.
  38. Jain, R., Jain, S., Raison, C.L., Maletic, V. Painful Diabetic Neuropathy is more than Pain Alone: Examining the Role of Anxiety and Depression as Mediators and Complicators. Current Diabetes Reports 2011; 11(4): 275-84.
  39. Felger, J.C., Alagbe, T., Pace, T.W.W., Woolwine, B.J., Raison, C.L., and Miller AH. Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression.Brain, Behavior and Immunity 2011; 25(6): 1094-8.
  40. Haroon, E., Raison, C.L., Miller, A.H. Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior. Neuropsychopharmacology 2012; 37(1): 137-62.
  41. Raison, C.L. & Miller, A.H. Is Depression an Inflammatory Disorder? Current Psychiatry Reports 2011; 13(6): 467-75.
  42. Felger, J.C., Cole, S.W., Pace, T.W.W., Hu, F., Woolwine, B.J., Doho, G.H., Raison, C.L., Miller, A.H. Molecular Signatures of Peripheral Blood Mononuclear Cells during Chronic Interferon-alpha Treatment: Relationship with Depression and Fatigue. Psychological Medicine 2012; 42: 1591-603.
  43. Raison, C.L. & Miller, A.H. The Evolutionary Significance of Depression in Pathogen Host Defense (PATHOS-D). Molecular Psychiatry 2013; 18::15-37.
  44. Reddy, S.D., Negi, L.T., Dodson-Lavelle, B.,Ozawa de-Silva, B., Pace, T.W., Cole, S.P., Raison, C.L., Craighead, L.W. Cognitively-Based Compassion Training: a promising prevention strategy for at-risk adolescents. Journal of Child and Family Studies 2012; Epub.
  45. Rook, G.A.W., Raison, C.L., Lowry, C.A. Can we vaccinate against depression. Drug Discovery Today 2012; 17: 451-8.
  46. Johnson, T.V., Abbasi, A., Ehrich, S.S., Kleris, R.S., Owen-Smith, A., Raison, C.L. Master, V.A. IPSS quality of life question: a possible indicator of depression among patients with lower urinary tract symptoms. Canadian Journal of Urology 2012; 19: 6100-4.
  47. McNutt, M.D., Liu S., Manatunga, A., Royster, E.B., Raison, C.L., Woolwine, B.J., Demetrashvili, M.F., Miller, A.H., Musselman, D.L. Neurobehavioral Effects of Interferon-α in Patients with Hepatitis-C: Symptom Dimensions and Responsiveness to Paroxetine. Neuropsychopharmacology 2012; 37:1444-54.
  48. Pace, T.W., Negi, L.T., Dodson-Lavelle, B., Ozawa-de Silva, B. Reddy, S.D., Cole, S.P., Danes, A., Craighead, L.W., Raison, C.L. Engagement with Cognitively-Based Compassion Training is associated with reduced salivary C-reactive protein from before to after training in foster care program adolescents. Psychoneuroendocrinology 2012; 38: 294-9.
  49. Raison, C.L., Haroon, E., Woolwine, B.J., Shuo, C., Haber, M. Rutherford, R., Miller, A.H. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. Archives of General Psychiatry 2012; 70: 31-41.
  50. Mascaro, J.S., Rilling, J.K., Negi, L.T., Raison, C.L. Compassion meditation enhances empathic accuracy and related neural activity. Social Cognitive and Affective Neuroscience 2012; 8: 48-55.
  51. Desbordes, G., Negi, L.T., Pace, T.W., Wallace, B.A., Raison, C.L., Schwartz, E.L. Effects of mindful-attention and compassion meditation training on amygdala response to emotional stimuli in an ordinary, non-meditative state. Frontiers in Neuroscience 2012; 6: 292.
  52. Hale, M.W., Raison, C.L., Lowry, C.A. Integrative physiology of depression and antidepressant drug action: implications for serotonergic mechanisms of action and novel therapeutic strategies for treatment of depression. Pharmacology & Therapeutics 2012; 137:108-18.
  53. Felger, J.C., Li, L., Marvar, P.J., Woolwine, B.J., Harrison,D.G., Raison, C.L., and Miller, A.H. Tyrosine Metabolism During Interferon-alpha Administration: Association with Fatigue and CSF Dopamine Concentrations.Brain, Behavior, and Immunity 2012; 31:153-60.
  54. Mascaro, J.S., Rilling, J.K., Negi, L.T., Raison, C.L. Pre-existing brain function predicts subsequent practice of mindfulness and compassion meditation. Neuroimage 2013; 69:35-42.
  55. Berg, J.M., Lilienfeld, S.O., Reddy, D., Latzman, R.D., Roose, A., Craighead, L.W., Pace, T.W., Raison, C.L. The Inventory of Callous and Unemotional Traits: A Construct-Validational Analysis in an At-Risk Sample. Assessment 2013; 20: 532-44.
  56. Miller, A.H., Haroon, E., Raison, C.L., Felger, J.C. Cytokine Targets in the Brain: Impact on Neurotransmitters and Neurocircuits. Depression & Anxiety 2013; 30::297-306.
  57. Rook, G.A.W., Lowry, C.A., Raison, C.L. Microbial “Old Friends,” immunoregulation and stress resilience. Evolution, Medicine, and Public Health 2013; 13: 46-64.
  58. Hanusch, K., Janssen, C.H., Billheimer, D, Jenkins, I., Spurgeon, E., Lowry, C.A., Raison, C.L. Whole Body Hyperthermia (WBH) for the Treatment of Major Depression: Associations with Thermoregulatory Cooling. American Journal of Psychiatry 2013; 170: 802-4.
  59. Mehta, D., Raison, C.L., Woolwine, B.J., Haroon, E., Binder, E.B., Miller, A.H., Felger, J.C. Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression. Brain, Behavior and Immunity 2012;31:205-15.
  60. Rook, G.A., Raison, C.L., Lowry, C.A. Childhood microbial experience, immunoregulation, inflammation and adult susceptibility to psychosocial stressors and depression in rich and poor countries. Evolution, Medicine, and Public Health 2013; 12: 14-17.
  61. Rook, G.A.W., Raison, C.L., Lowry, C.A. Microbial “Old Friends,” immunoregulation and socio-economic status. Clinical and Experimental Immunology 2014; 177: 1-12.
  62. Whisman, M.A., Li, A., Sbarra, D.A., Raison, C.L. Marital quality and diabetes: results from the health and retirement study. Health Psychology 2014; 33: 832-40.
  63. Rook, G.A., Raison, C.L., Lowry, C.A. Microbiota, immunoregulatory old friends and psychiatric disorders. Advances in Experimental Medical Biology 2014; 817: 319-56.
  64. Raison C.L. Inflammatory depression: a trifecta of trouble. Journal of Clinical Psychiatry 2014; 75: 663-4.
  65. Rook, G.A., Lowry, C.A., Raison, C.L. Hygiene and other early childhood influences on the subsequent function of the immune system. Brain Research 2014; S0006-8993(14)00481-8.
  66. Maletic V & Raison, C.L. Integrated neurobiology of bipolar disorder. Frontiers in Psychiatry 2014; 5:98
  67. Weinberger, J.F., Raison, C.L., Montague, A.K., Woolwine, B.J., Felger, J.C., Haroon, E. Miller, A.H.Inhibition of Tumor Necrosis Factor Improves Sleep Continuity in Patients with Treatment Resistant Depression and High Inflammation. Brain, Behavior and Immunity 2014: 47: 193-200.
  68. Raison, C.L., Hale, M.W., Williams, L.E., Wager, T.D., Lowry, C.A. Somatic influences on subjective well-being and affective disorders: the convergence of thermosensory and central serotonergic systems. Frontiers in Psychology, Section Cognition 2015; Jan 13; 5: 1580
  69. Maletic V& Raison C. The integrated neurobiology of bipolar disorder. Frontiers in Psychiatry 2014;5:98. doi: 10.3389/fpsyt.2014.00098.
  70. Miller, A.H. & Raison, C.L. Where the Rubber Meets the Road: Are Anti-inflammatory Therapies Viable Treatments for Psychiatric Disorders? JAMA Psychiatry 2015; 72: 527-8.
  71. Mascaro,J.S., Darcher, A., Negi, L.T. Raison, C.L. The neural mediators of kindness-based meditation: a theoretical model.Frontiers in Psychology, Section Cognition2015; 12: 109.
  72. Pruimboom, L., Raison, C.L., Muskiet, F.A.J.Physical activity protects the human brain against metabolic stress induced by a postprandial and chronic inflammation. Behavioural Neurology 2015; 2015:569869
  73. Dodds,S.E., Pace, T.W.W., Bell, M.L., Fiero, M., Negi, L.T., Raison, C.L, and Weihs, K. Feasibility of Cognitively-Based Compassion Training(CBCT) for Breast Cancer Survivors: A Randomized, Wait List Controlled Pilot Study. Supportive Care in Cancer 2015; 23: 3599-608.
  74. Miller, A.H. & Raison, C.L. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 2016; 16: 22-34.
  75. Felger, J.C., Haroon, E., Woolwine, B.J., Raison, C.L., and Miller, A.H. 2016. Interferon-alpha-Induced Inflammation is Associated with Reduced Glucocorticoid Negative Feedback Sensitivity and Depression in Patients with Hepatitis C Virus. Physiology & Behavior 2016; 166:14-21
  76. Bollich, K.L., Doris, J.M., Vazire, S, Raison, C.L., Jackson, J.J. Mehl, M.R. Eavesdropping on Character: Assessing Everyday Moral Behaviors. Journal of Personality Research 2016; 61:15-21
  77. Janssen, C.W. Lowry, C.A., Mehl, M.R., Allen, J.J.B., Kelly, K.L., Gartner, D.E., Medrano, A., Begay, T.K., Rentscher, K., White, J.J., Fridman, A., Roberts, L.J., Robbins, M.L., Hanusch, K. Cole, S.P., Raison, C.L. Whole body hyperthermia for the treatment of major depressive disorder: a randomized clinical trial. JAMA Psychiatry 2016; 73: 780-95
  78. Raison, C.L. The promise and limitations of anti-inflammatory agents for the treatment of major depressive disorder. Current Topics in Behavior Neurosciences 2016; epub
  79. Pruimboom, L., Ruiz-Nunez, B., Raison, C.L., Muskiet, F.A.J. Influence of 10 days mimic of our ancient lifestyle on anthropometrics and parameters of metabolism and inflammation. JBiomedical Research International 2016;2016:6935123
  80. Lowry, C.A., Smith, D.G., Siebler, P.H., Schmidt, D., Stamper, C.E., Hassell, J.E. Jr., Yamashita, P.S., Fox, H.H., Reber, S.O., Brenner, L.A., Hoisington, A.J., Postloche, T.T., Kinney, K.A., Marciani, D., Hernandex, M., Hemmings, S.M., Malan-Muller, S., Wrigth, K.P., Knight, R., Raison, C.L., Rook, G.A. The microbiota, immunoregulation, and mental health: implications for public health. Current Environmental Health Reports 2016;3(3):270-86
  81. Raison, C.L., Lowry, C.A., Janssen, C.W. Hyperthermia for major depression?—reply. JAMA Psychiatry 2016;73(10):1096-1097
  82. Reber, S.O., Siebler, P.H., Donner, N.C., Morton, J.T., Smith, D.G., Kopelman, J.M., Lowe, K.R., Wheeler, K.J., Fox, J.H., Hassell, J.E. Jr., Greenwood, B.N., Jansch, C., Lechner, A., Schmidt, D., Uschold-Schmidt, N., Füchsl, A.M., Langgartner, D., Walker, F.R., Hale, M.W., Lopez Perez, G., Van Treuren, W., González, A., Halweg-Edwards, A.L., Fleshner, M.,Raison,C.L., Rook, G.A., Peddada, S.D.,Knight,R.,Lowry,C.A.Immunization with a heat-killed preparation of the environmental bacterium Mycobacterium vaccae promotes stress resilience in mice. Proc Natl Acad Sci U S A 2016;113(22):E3130-9.
  83. Raison, C.L. &Miller, A.H. Pathogen-Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance. Neuropsychopharmacology 2017; 42(1): 5-27
  84. Reed, R.G., O’Connor, M-F. Pace, T.W.W., Raison, C.L., Butler, E.A. Dyadic coping and salivary interleukin-6 responses to interpersonal stress. Journal of Family Psychology; Epub
  85. Mascaro, J.S., Kelley, S., Darcher, A., Negi, L.T., Worthman, C., Miller, A.H., Raison, C.L. Meditation buffers medical student compassion from the deleterious effects of depression. Journal of Positive Psychology 2016; Epub
  86. Kohler, C.A., Freitas, T.H., Maes, M., de Andrade, N.Q., Liu, C.S., Fernandes, B.S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., Raison, C.L., Miller, B.J., Lanctot, K.L., Carvalho, A.F.Peripheral cytokine and chemokine alterations in depression: an up-dated meta-analysis of 82 studies. Acta Psychiatrica Scandinavia 2017; 135(5):373-387
  87. Kohler, C.A., Freitas, T.H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., Andrede, N.Q., Morris, G., Fernandes, B.S., Brunoni, A.R., Hermann, N., Raison, C.L., Miller, B.J., Lactot, K.L., Carvalho, A.Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment: systematic review and meta-analysis. Molecular Neurobiology 2017; Epub.
  88. Hale, M.W., Lukkes, J.L., Dady, K.F., Kelly, K.J., Paul, E.D., Smith, D.G.,Raison, C.L., Lowry, C.A. Whole-body hyperthermia and a subthreshold dose of citalopram act synergistically to induce antidepressant-like behavioral responses in adolescent rats. Progress in Neuropsychopharmacology and Biological Psychiatry 2017; 79(Pt B): 162-8
  89. Mehl, M., Raison, C.L., Pace T., Cole, S.W. Natural language indicators of differential gene regulation in the human immune system. Proceedings of the Natl Acad Sci U S A 2017; 114(47):12554-59
  90. Raison, C.L. & Raichlen, D.A. An evolutionary perspective on nutrition and social decision making. Proc Natl Acad Sci U S A2018; Epub
  91. Quinn, A.M., Williams, A.R., Sivilli, T.I., Raison, C.L., and Pace, T.W.W. The plasma interleukin-6 response to acute psychosocial stress in humans is detected by a magnetic multiplex assay: Comparison to high-sensitivity ELISA. Stress 2018; epub
  92. Milek, A., Butler, E. A., Tackman, A. M., Kaplan, D. M., Raison, C. L., Sbarra, D. A., Vazire, S., & Mehl, M. R. (in press). “Eavesdropping on happiness” revisited: A pooled, multi-sample replication of the association between life satisfaction and observed daily conversation quantity and quality. Psychological Science 2018; Epub
  93. Raison, C.L., Pikalov, A., Siu, C., Tsai J, Koblan, K., Loebe,l A. C-reactive protein and response to lurasidone in patients with bipolar depression.Brain Behav Immun 2018;73:717-724
  94. Hale, M.W., Lukkes, J.L., Dady, K.F., Kelly, K.J., Paul, E.D., Smith, D.G., Heinze, J.D.,Raison, C.L., Lowry, C.A. Interactions between whole-body heating and citalopram on body temperature, antidepressant-like behaviour, and neurochemistry in adolescent male rats. Behavior Brain Research 2018; epub
  95. Kaplan, D.M., Raison, C.L., Milek, A., Tackman, A.M., Pace, T.W.W., Mehl, M.R. Dispositional mindfulness in daily life: naturalistic observation study. PLoS One 2018; epub.
  96. Poehlmann-Tynan, J., Engbretson, A., Vigna, A.B., Weymouth ,LA, Burnson, C., Zahn-Waxler, C., Kapoor, A., Gerstein, E.D., Fanning, K.A., Raison, C.L. Cognitively-Based Compassion Training for parents reduces cortisol in infants and young children. Infant Mental Health Journal 2019; Epub
  97. Raison, C.L., Siu, C., Pikalov, A., Tocco, M., Loebel, A. C-reactive protein and response to lurasidone treatment in children and adolescents with bipolar I depression: Results from a placebo-controlled trial. Brain, Behavior and Immunity 2019, Epub.
  98. Goldberg, S. B., Pace, B. T., Nicholas, C. R., Raison, C. L., & Hutson, P. R. (in press). The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis. Psychiatry Research 2020; Epub.
  99. Perez, M., Raison, C.L., Coe, C.,Cook, D., Meyer, J. Cytokine responses across submaximal exercise intensities in women with major depressive disorder. Brain, Behavior, and Immunity –Health2020; Epub.
  100. Ash, M.J., Walker, E.R., DiClemente, R.J., Florian, M.P., Palmer, P.K., Wehrmeyer, K., Negi, L.T., Grant, G.H., Raison CL, Mascaro JS. Compassion Meditation Training for Hospital Chaplain Residents: A Pilot Study. J Health Care Chaplain 2020 Feb 13:1-16
  101. Yaklin S, Jain R, Cole SP, Raison C, Rolin D, Jain S. HERO Wellness Scale: Examining a new mental wellness scale. Ann Clin Psychiatry 2020;32(1):33-40.
  102. Mansur, R.B., Delgado-Peraza, F., Subramaniapillai, M., Lee, Y., Iacobucci, M., Rodrigues, N., Rosenblat, J.D., Brietzke, E., Cosgrove, V.E., Kramer, N.E., Suppes, T., Raison, C.L., Chawla, S., Nogueras-Ortiz, C., McIntyre, R.S., Kapogiannis, D. Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression.Cells 2020 Apr 6;9(4).
  103. Knight, J.M., Costanzo, E.S., Singh, S., Yin, Z., Szabo, A., Pawar, D.S., Hillard, C.J., Rizzo, J.D., D’Souza, A., Pasquini, M., Coe, C.L., Irwin, M.R., Raison, C.L., Brobyski, W.R. The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill. Translational Psychiatry 2021; 11(1): 58
  104. Ash, M.J., Walker, E.R., DiClemente, R.J., Florian, M.P., Palmer, P.K., Wehrmeyer, K., Negi, L.T., Grant, G.H., Raison, C.L. Compassion meditation training for hospital chaplain residents: a pilot study. Journal of Health Care Chaplaincy 2021; 27(4): 1910206.
  105. Mascaro, J.S., Palmer, P.K., Ash, M.J., Peacock, C., Escoffery, C., Grant, G.H., Raison, C.L. International Journal of Environmental Research and Public Health 2021; 18(22): 11855
  106. Mason, A.E., Fisher, S.M., Chowdhary, A., Guvva, E., Vesna, D., Floyd, E., Fender, S.B., Raison, C. Feasibility and acceptability of a whole-body hyperthermia (WBH) protocol. International Journal of Hyperthermia 2021; 38(1): 1529-38.
  107. Lee Y, Mansur RB, Brietzke E, Kapogiannis D, Delgado-Peraza F, Boutilier JJ, Chan TCY, Carmona NE, Rosenblat JD, Lee J, Maletic V, Vinberg M, Suppes T, Goldstein BI, Ravindran AV, Taylor VH, Chawla S, Nogueras-Ortiz C, Cosgrove VE, Kramer NE, Ho R, Raison CL, McIntyre RS.  Peripheral inflammatory biomarkers define biotypes of bipolar depression.Mol Psychiatry 2021 Jul;26(7):3395-340.
  108. Mason AE, Fisher SM, Chowdhary A, Guvva E, Veasna D, Floyd E, Fender SB, Raison C. Feasibility and acceptability of a Whole-Body hyperthermia (WBH) protocol. Int J Hyperthermia 2021;38(1):1529-1535
  109. Mascaro JS, Palmer PK, Ash MJ, Peacock C, Sharma A, Escoffery C, Raison C. Feasibility, Acceptability, and Preliminary Effectiveness of a Compassion-Centered Team Intervention to Improve Clinical Research Coordinator Resilience and Well-Being. JCO Oncol Pract 2021;17(7):e936-e946.
  110. Palmer PK, Wehrmeyer K, Florian MP, Raison C, Idler E, Mascaro JS. The prevalence, grouping, and distribution of stressors and their association with anxiety among hospitalized patients. PLoS One 2021 Dec 6;16(12):e0260921.
  111. Raison CL, Jain R, Penn AD, Cole SP, Jain S. Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.Front Psychiatry 2022 Mar 15;13:831092. doi: 10.3389
  112. Mascaro JS, Florian MP, Ash MJ, Palmer PK, Sharma A, Kaplan DM, Palitsky R, Grant G, Raison CL. Learning Compassion and Meditation: A Mixed-Methods Analysis of the Experience of Novice Meditators. Front Psychol 2022 Apr 5;13:805718. doi: 10.3389.
  113. Mac Giollabhui N, Foster S, Lowry CA, Mischoulon D, Raison CL, Nyer M. Interleukin-6 receptor antagonists in immunopsychiatry: Can they lead to increased interleukin-6 in the central nervous system (CNS) and worsening psychiatric symptoms?Brain Behav Immun 2022 Jul;103:202-204. doi: 10.1016.
  114. Bradberry MM, Gukasyan N, Raison CL. Toward Risk-Benefit Assessments in Psychedelic- and MDMA-Assisted Therapies.JAMA Psychiatry 2022 Jun 1;79(6):525-527. doi: 10.1001.
  115. Taylor MR, Hillard CJ, Drobyski WR, Szabo A, Johnson BD, Zhu F, Raison CL, Cole SW, Knight JM. The effect of tocilizumab on patient reported outcomes and inflammatory biomarkers in hematopoietic cell transplantation. Brain Behav Immun Health 2022 Jun 11;23:100480. doi: 10.1016.
  116. Kaplan, D. M., Mehl, M. R., Pace, Thaddeus W. W., Negi, L. T., Ozawa-de Silva, Brendan, Lavelle, B. D., Sivilli, T., Williams, A., Comstock, T., Price, B., Medrano, V., Robbins, M. L., Cole, S. P., Craighead, W. E., Raison, C. Implications of a “Null” Randomized Controlled Trial of Mindfulness and Compassion Interventions in Healthy Adults. Mindfulness 2022; 5(13): 1197-1213.
  117. Kiluk BD, Kleykamp BA, Comer SD, Griffiths RR, Huhn AS, Johnson MW, Kampman KM, Pravetoni M, Preston KL, Vandrey R, Bergeria CL, Bogenschutz MP, Brown RT, Dunn KE, Dworkin RH, Finan PH, Hendricks PS, Houtsmuller EJ, Kosten TR, Lee DC, Levin FR, McRae-Clark A, Raison CL, Rasmussen K, Turk DC, Weiss RD, Strain EC. Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review. JAMA Psychiatry 2023 Jan 1;80(1):84-92. doi: 10.1001.
  118. Miller AH, Raison CL. Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies.Mol Psychiatry 2023 Jan;28(1):68-75. doi: 10.1038.
  119. Ortiz Bernal AM, Raison CL, Lancelotta RL, Davis AK. Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon's predictors and its emotional valence.Front Psychiatry 2022 Nov 29;13:1049643. doi: 10.3389.
  120. Atari M, Mehl MR, Graham J, Doris JM, Schwarz N, Davani AM, Omrani A, Kennedy B, Gonzalez E, Jafarzadeh N, Hussain A, Mirinjian A, Madden A, Bhatia R, Burch A, Harlan A, Sbarra DA, Raison CL, Moseley SA, Polsinelli AJ, Dehghani M. The paucity of morality in everyday talk. Sci Rep 2023;13(1):5967.
  121. Flux MC, Smith DG, Allen JJB, Mehl MR, Medrano A, Begay TK, Middlemist BH, Marquart BM, Cole SP, Sauder CJ, Lowry CA, Raison CL. Association of plasma cytokines and antidepressant response following mild-intensity whole-body hyperthermia in major depressive disorder. Transl Psychiatry 2023;13(1):132.
  122. Miller AH & Raison CL. Psychedelics and ketamine are a symptom of psychiatry's woes, not a cure. Molecular Psychiatry 2023; 28(8):3167-3168. doi: 10.1038/s41380-023-02132-w
  123. Palitsky R, Kaplan DM, Peacock C, Zarrabi AJ, Maples-Keller JL, Grant GH, Dunlop BW, Raison CL. Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies JAMA Psychiatry 2023; 80(7):743-749. doi: 10.1001/jamapsychiatry.2023.1554.
  124. Danvers, A.F., Efinger, L.D., Mehl, M.R., Helm, P.J., Raison, C.L., Polsinelli, A.J., Moseley, S.A., Sbarra, D.A., Loneliness and Time Alone in Everyday Life: A Descriptive-Exploratory Study of Subjective and Objective Social Isolation. Journal of Research in Personality 2023; doi: https://doi.org/.10.1016/j.jrp.2023.104426
  125. Raison CL, Sanacora G, Woolley J, Heinzerling K, Dunlop BW, Brown RT, Kakar R, Hassman M, Trivedi RP, Robison R, Gukasyan N, Nayak SM, Hu X, O'Donnell KC, Kelmendi B, Sloshower J, Penn AD, Bradley E, Kelly DF, Mletzko T, Nicholas CR, Hutson PR, Tarpley G, Utzinger M, Lenoch K, Warchol K, Gapasin T, Davis MC, Nelson-Douthit C, Wilson S, Brown C, Linton W, Ross S, Griffiths RR. Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial. JAMA 2023;330(9):843-853.
  126. Garakani A, Alexander JL, Sumner CR, Pine JH, Gross LS, Raison CL, Aaronson ST, Baron DA. Psychedelics, With a Focus on Psilocybin: Issues for the Clinician. Journal of Psychiatric Practice 2023;29(5):345-353.
  127. Tyler MP, Wright BJ, Beaton R, Monger K, Raison CL, Lowry CA, Evans L, Hale MW. Severity of depressive symptoms moderates the sympathoinhibitory effect of local skin warming following exposure to a social stressor. Psychoneuroendocrinology 2024:159:106420. doi: 10.1016/j.psyneuen.2023.106420. Epub 2023 Oct 18
  128. Nyer MB, Hopkins LB, Nagaswami M, Norton R, Streeter CC, Hoeppner BB, Sorensen CEC, Uebelacker L, Koontz J, Foster S, Dording C, Giollabhui NM, Yeung A, Fisher LB, Cusin C, Jain FA, Pedrelli P, Ding GA, Mason AE, Cassano P, Mehta DH, Sauder C, Raison CL, Miller KK, Fava M, Mischoulon D. A Randomized Controlled Trial of Community-Delivered Heated Hatha Yoga for Moderate-to-Severe Depression. Journal of Clinical Psychiatry 2023;84(6):22m14621. doi: 10.4088/JCP.22m14621.
  129. Peacock C, Mascaro JS, Brauer E, Zarrabi AJ, Dunlop BW, Maples-Keller JL, Grant GH, Raison CL, Rab F, Palitsky R. Spiritual health practitioners' contributions to psychedelic assisted therapy: A qualitative analysis. PLoS One. 2024;19(1):e0296071. doi: 10.1371/journal.pone.0296071.
  130. Mascaro JS, Palmer PK, Willson M, Ash MJ, Florian MP, Srivastava M, Sharma A, Jarrell B, Walker ER, Kaplan DM, Palitsky R, Cole SP, Grant GH, Raison CL The Language of Compassion: Hospital Chaplains' Compassion Capacity Reduces Patient Depression via Other-Oriented, Inclusive Language. Mindfulness (N Y) 2023;14(10):2485-2498. doi: 10.1007/s12671-022-01907-6.
  131. Mason AE, Kasl P, Soltani S, Green A, Hartogensis W, Dilchert S, Chowdhary A, Pandya LS, Siwik CJ, Foster SL, Nyer M, Lowry CA, Raison CL, Hecht FM, Smarr BL. Elevated body temperature is associated with depressive symptoms: results from the TemPredict Study. Sci Rep 2024;14(1):1884. doi: 10.1038/s41598-024-51567-w.
  132. Mascaro JS, Florian MP, Brauer E, Palmer PK, Ash MJ, Shelton M, Palitsky R, Kaplan DM, Rana S, Escoffery C, Raison CL, Grant GH. A mixed-method evaluation of implementation determinants for chaplain intervention in a hospital setting. J Health Care Chaplain 2024;30(3):226-244. doi: 10.1080/08854726.2024.2323375.
  133. Mac Giollabhui N, Lowry CA, Nyer M, Foster SL, Liu RT, Smith DG, Cole SP, Mason AE, Mischoulon D, Raison CL. The antidepressant effect of whole-body hyperthermia is associated with the classical interleukin-6 signaling pathway. Brain Behav Immun 2024:801-806. doi: 10.1016/j.bbi.2024.04.040.
  134. Mason AE, Chowdhary A, Hartogensis W, Siwik CJ, Lupesko-Persky O, Pandya LS, Roberts S, Anglo C, Moran PJ, Nelson JC, Lowry CA, Patrick RP, Raison CL, Hecht FM. Feasibility and acceptability of an integrated mind-body intervention for depression: whole-body hyperthermia (WBH) and cognitive behavioral therapy (CBT). Int J Hyperthermia 2024;41(1):2351459. doi: 10.1080/02656736.2024.2351459.
  135. Brouwer A, Carhart-Harris RL, Raison CL. Psychotomimetic compensation versus sensitization. Pharmacol Res Perspect 2024;12(4):e1217. doi: 10.1002/prp2.1217.
  136. Siegel JS, Subramanian S, Perry D, Kay BP, Gordon EM, Laumann TO, Reneau TR, Metcalf NV, Chacko RV, Gratton C, Horan C, Krimmel SR, Shimony JS, Schweiger JA, Wong DF, Bender DA, Scheidter KM, Whiting FI, Padawer-Curry JA, Shinohara RT, Chen Y, Moser J, Yacoub E, Nelson SM, Vizioli L, Fair DA, Lenze EJ, Carhart-Harris R, Raison CL, Raichle ME, Snyder AZ, Nicol GE, Dosenbach NUF. Psilocybin desynchronizes the human brain. Nature 2024;632(8023):131-138. doi: 10.1038/s41586-024-07624-5.
  137. Palmer PK, Siddiqui Z, Moore MA, Grant GH, Raison CL, Mascaro JS. Hospital Chaplain Burnout, Depression, and Well-Being during the COVID-19 Pandemic. Int J Environ Res Public Health 2024;21(7):944. doi: 10.3390/ijerph21070944.
  138. Palitsky R, Kaplan DM, Perna J, Bosshardt Z, Maples-Keller JL, Levin-Aspenson HF, Zarrabi AJ, Peacock C, Mletzko T, Rothbaum BO, Raison CL, Grant GH, Dunlop BW. A framework for assessment of adverse events occurring in psychedelic-assisted therapies. J Psychopharmacol 2024;38(8):690-700. doi: 10.1177/02698811241265756.
  139. Ricon-Becker I, West TN, Fredrickson BL, Kaplan DM, Mehl MR, Raison CL, Cole SW. Predicting psychosocial intervention response from baseline gene expression. Brain Behav Immun 2024:121:331-339.
  140. Tyler MP, Wright BJ, Raison CL, Lowry CA, Evans L, Hale MW. Temperature (Austin) 2024;11(3):266-279. doi: 10.1080/23328940.2024.2374097.
  141. Rab SF, & Raison CL, Marseille E. An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United States. Psychedelics: The Pharmacology of Psychedelics 2024; epub
  142. Nicholas CR, Banks MI, Lennertz RC, Wenthur CJ, Krause BM, Riedner BA, Smith RF, Hutson PR, Sauder CJ, Dunne JD, Roseman L, Raison CL. Co-administration of midazolam and psilocybin: differential effects on subjective quality versus memory of the psychedelic experience. Transl Psychiatry 2024;14(1):372. doi: 10.1038/s41398-024-03059-8.
  143. Palitsky, R., Maples-Keller, J., Peacock, C., Dunlop, B. W., Mletzko, T., Raison, C. L., Grant, G. H., Chao, S., Shub, I., Mendelbaum-Kweller, M., Smolyar, L., Kaplan, D. M., Rothbaum, B., Zarrabi, A. J. (under review) A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers. Psychotherapy2024; epub.
  144. Tononi G, Raison C. Artificial intelligence, consciousness and psychiatry. World Psychiatry 2024;23(3):309-310. doi: 10.1002/wps.21222. 

Return to Charles Raison's Bio